(Q43047002)

12 November 2017

Evaluation of recombinant Kunjin replicon SIV vaccines for protective efficacy in macaques (English)

1 reference

12 November 2017

1

1 reference

12 November 2017

2

1 reference

12 November 2017

Alexander A. Khromykh

15

1 reference

12 November 2017

Jeanette C Reece

11

0 references

Andreas Suhrbier

14

object named as

Andreas Suhrbier

1 reference

12 November 2017

8

Rosemarie D Mason

1 reference

12 November 2017

Vlad V Mokhonov

3

1 reference

12 November 2017

Ekaterina I Mokhonova

4

1 reference

12 November 2017

Caroline S Fernandez

5

1 reference

12 November 2017

Sheilajen Alcantara

6

1 reference

12 November 2017

Erik Rollman

7

1 reference

12 November 2017

Liyen Loh

9

1 reference

12 November 2017

Viv Peut

10

1 reference

12 November 2017

Xiang Ju Wang

12

1 reference

12 November 2017

Kim M Wilson

13

1 reference

12 November 2017

language of work or name

English

0 references

publication date

12 February 2008

1 reference

12 November 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

12 November 2017

374

1 reference

12 November 2017

2

1 reference

12 November 2017

528-534

1 reference

HIV vaccine failure prompts Merck to halt trial

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Cross-Reactive T-Cell Responses to the Nonstructural Regions of Dengue Viruses among Dengue Fever and Dengue Hemorrhagic Fever Patients in Malaysia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Comparative evaluation of simian, simian-human, and human immunodeficiency virus infections in the pigtail macaque (Macaca nemestrina) model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

HIV/AIDS. Vaccine results lose significance under scrutiny

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Vaccine-induced T cells control reversion of AIDS virus immune escape mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag c

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Antibody responses against HIV in rhesus macaques following combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Tetracycline-inducible packaging cell line for production of flavivirus replicon particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Broad cross-reactivity with marked fine specificity in the cytotoxic T cell response to flaviviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

An HIV vaccine--evolving concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

HIV vaccine design: insights from live attenuated SIV vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodefi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Killing kinetics of simian immunodeficiency virus-specific CD8+ T cells: implications for HIV vaccine strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

The pigtail macaque MHC class I allele Mane-A*10 presents an immundominant SIV Gag epitope: identification, tetramer development and implications of immune escape and reversion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Dysfunction of simian immunodeficiency virus/simian human immunodeficiency virus-induced IL-2 expression by central memory CD4+ T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

Characterization of immune responses elicited in macaques immunized sequentially with chimeric VEE/SIN alphavirus replicon particles expressing SIVGag and/or HIVEnv and with recombinant HIVgp140Env protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.01.006

10.1016/J.VIROL.2008.01.006

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference